The guideline on sponsor management of investigational medicinal products ("IMPs") for use in clinical trials that was published by the European Medicines Agency ("EMA") on 14 September 2022...
In December 2022, the European Commission published an updated version of the Q&A guidance on the Clinical Trials Regulation ("CTR"). This new version was issued shortly ahead of the 31 January 2023...